Johnson Matthey Share Discussion Threads

[jackdaw4243] 19/4/2021 11:12

Added a few at £32.298 it's looking undervalued on the world rush to battery technology

[philanderer] 16/4/2021 13:41

Johnson Matthey part of new European consortium to develop advanced fuel cell technology for heavy duty trucks HTTPS://www.prnewswire.com/news-releases/johnson-matthey-part-of-new-european-consortium-to-develop-advanced-fuel-cell-technology-for-heavy-duty-trucks-301269280.html

[philanderer] 14/4/2021 10:00

UBS RAISES JOHNSON MATTHEY PRICE TARGET TO 2,500 (2,300) PENCE - 'SELL'

[philanderer] 12/4/2021 10:32

JEFFERIES RAISES JOHNSON MATTHEY PRICE TARGET TO 4,100 (3,875) PENCE - 'BUY'

[philanderer] 09/4/2021 10:51

Guinness’ Riley backs ‘Marmite’ stock Johnson Matthey ‘Marmite’ stock Johnson Matthey (JMAT) is ‘overlooked’ and cheap, according to Guinness fund manager Will Riley. The specialist chemicals group is the seventh largest holding in Riley’s £407m Guinness Sustainable Energy fund, making up 3.8% of the portfolio. He said the company was a ‘bit of a Marmite name in the market’. Its core business is catalytic converters for diesel engines and it struggled last year as the automotive industry slowed down. ‘In terms of its newer businesses, Johnson is quite interesting on a couple of angles,’ said Riley. The manager noted its involvement in supplying chemicals for batteries for electric vehicles as well as its hydrogen division looking at fuel cells. ‘It’s a company that’s got quite big optionality and fundamentally we also think it’s quite cheap,’ he said. ‘It’s a bit of an overlooked name so [with] the combination of a recovery in its core auto division on the converter side and these clean air divisions, we like what we see. And actually, it’s one of our best performers this year.’ The company’s shares closed up 1.5%, or 46p, at £31.45 on Thursday. HTTPS://citywire.co.uk/funds-insider/news/expert-view-johnson-matthey-deliveroo-carnival-hiscox-and-ascential/a1492156?section=funds-insider&_ga=2.246421059.635412063.1617961766-315486189.1617961766#i=2

[philanderer] 09/4/2021 10:47

Jaroslaw Pominkiewicz, an analyst at Jefferies, estimated the health business, which produces active pharmaceutical ingredients, could be worth about £2bn. “Health’s strategic review could result in unlocking significant value for the group,” he said. https://www.ft.com/content/0367d092-2734-4335-9740-523bd0fd666f

[philanderer] 09/4/2021 10:29

CREDIT SUISSE RAISES JOHNSON MATTHEY PRICE TARGET TO 3,600 (3,500) PENCE - 'OUTPERFORM'

[philanderer] 08/4/2021 14:12

Johnson Matthey moved into pole position in the FTSE 100 Index today as the maker of catalytic converters revealed more detail on its plans in the clean air arena. One in every three new cars carries one of JM’s converters, but with the transition towards electric vehicles well under way the blue-chip company is increasingly pivoting its business toward supplying materials for batteries and hydrogen fuel cells. The need to drive cashflow from its more established operations towards these newer sustainable technologies means JM has started a review of its Health business, which makes ingredients for opioid addiction therapies. As well as the review announced today, the chemicals company also told investors that the recent rebound in activity in auto manufacturing should mean its performance for the year to last month will be towards the top end of City expectations. Shares jumped by 3% to 3,205p at the top of the FTSE 100 index risers board today, with sentiment further boosted by the promise that the review of the Health business will focus on maximising value for shareholders. Hargreaves Lansdown analyst Laura Hoy said: “We wonder if potential sale proceeds would be used to ramp up its electric vehicle transition, or if management is hoping to unearth a new growth opportunity outside autos. The former makes sense, considering Johnson Matthey’s entrenchment in the auto industry.” HTTPS://www.standard.co.uk/business/markets/ftse-100-shares-b928488.html#r3z-addoor

[philanderer] 08/4/2021 11:13

In equity markets, Johnson Matthey was sitting pretty at the top of the FTSE 100 index after the specialty chemicals business said its annual performance would be around the top end of market expectations as it announced a strategic review of its health business. ADVFN

[philanderer] 07/4/2021 00:44

Trading update thursday

[philanderer] 31/3/2021 17:03

Dog of the day in my lot.

[philanderer] 24/3/2021 20:13

Johnson Matthey to supply technology to methanol plant HTTPS://www.stockmarketwire.com/article/7198097/Johnson-Matthey-to-supply-technology-to-methanol-plant.html

[philanderer] 24/3/2021 14:38

Jefferies: Johnson Matthey is underrated and cheap The market is too ‘sceptical’ about how Johnson Matthey (JMAT) will be impacted by the shift to electric vehicles, says Jefferies, which has initiated coverage on the chemicals group. Analyst Jaroslaw Pominkiewicz initiated coverage with a ‘buy’ recommendation and target price of £38.75 on the stock, which closed down 0.4%, or 12p, at £29.55 on Tuesday. ‘The market is too sceptical about the impact of the shift from internal combustion to electric vehicles on Johnson Matthey’s catalysts business and underrates its growing exposure to energy transition materials, including batteries,’ he said. Although the group has suffered Covid-19 headwinds, Pominkiewicz said they see ‘strong recovery potential’ and that trading on a full year 2022 price/earnings ratio of 13.5 times ‘the stock is cheap’. HTTPS://citywire.co.uk/funds-insider/news/expert-view-cineworld-futura-medical-johnson-matthey-yougov-and-clipper/a1485159?section=funds-insider&_ga=2.168127714.298281559.1616596520-452674706.1616596520#i=3

[philanderer] 24/3/2021 10:21

BARCLAYS CUTS JOHNSON MATTHEY PRICE TARGET TO 2,540 (2,570) PENCE - 'UNDERWEIGHT'

[philanderer] 23/3/2021 11:11

JEFFERIES INITIATES JOHNSON MATTHEY WITH 'BUY' - TARGET 3,875 PENCE

[philanderer] 20/3/2021 11:49

Sibanye partners with Johnson Matthey in net zero push HTTPS://www.miningglobal.com/technology/sibanye-partners-johnson-matthey-net-zero-push

[philanderer] 03/3/2021 15:33

BERENBERG RAISES JOHNSON MATTHEY PRICE TARGET TO 3,700 (3,200) PENCE - 'BUY' DEUTSCHE BANK RAISES JOHNSON MATTHEY PRICE TARGET TO 3,300 (2,450) PENCE - 'HOLD'

[mansell59] 01/3/2021 10:26

Breached the £30 mark today. Fully expect this to keep rising

[philanderer] 17/2/2021 09:41

ALPHAVALUE RAISES JOHNSON MATTHEY TO 'REDUCE' ('SELL') - TARGET 2,874 PENCE

[philanderer] 17/2/2021 00:09

Johnson Matthey (JM) has joined the All-Party Parliamentary Group (APPG) on Hydrogen, a group focused on raising awareness of and building support for large-scale hydrogen projects in the UK. The cross-party group of parliamentarians was established in July 2018 and has provided a forum for engagement with government and industry and emphasised the importance of hydrogen in the climate change debate. HTTPS://www.h2-view.com/story/johnson-matthey-joins-uk-appg-on-hydrogen/

[philanderer] 16/2/2021 11:40

Johnson Matthey adds support to UK All Party Parliamentary Group on Hydrogen HTTPS://matthey.com/en/news/2021/johnson-matthey-adds-support-to-uk-all-party-parliamentary-group-on-hydrogen

[philanderer] 16/2/2021 00:51

Platinum Soars Past $1,300 an Ounce for First Time in Six Years Read more at: [...] Copyright © BloombergQuint

[philanderer] 15/2/2021 11:55

Threadneedle’s green bet on Johnson Matthey Sonal Sagar, manager of the Threadneedle UK Sustainable Equity fund, believes Boris Johnson’s 10-point plan for a green recovery will benefit speciality chemicals group Johnson Matthey (JMAT). The manager of the £25m fund said the pandemic had boosted the outlook for sustainable opportunities. ‘Boris Johnson’s 10-point plan for a green revolution – which includes green energy, transport, climate change, and technology – should benefit a number of UK companies. And we should be beneficiaries of that,’ she said. Sagar thinks Johnson Matthey, in particular, can ride the wave of green investment. ‘It is invested in electric vehicle technology and has a leading position in hydrogen and fuel cell technology so it should be a beneficiary,’ she said. Shares in Johnson Matthey closed up 1.5%, or 44p, at £30.03 on Friday. HTTPS://citywire.co.uk/funds-insider/news/the-expert-view-jd-wetherspoon-johnson-matthey-and-gsk/a1464782?section=funds-insider&_ga=2.146999540.276331474.1613389957-75062472.1613389957#i=3

[philanderer] 12/2/2021 15:39

We've had a few goes at 3000p ;-)